Attention Laurel Patients:¬† Effective, Tues May 28th, the new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707……¬† Attention¬† Annapolis Patients: The One Community in Care event will be held on June 8th from 11am-2pm in the Annapolis parking lot.

Trial Protocol ID USOR 22159_CELC-G-301_VIKTORIA-1

Trial Description

A Phase 3, Open-Label, Randomized, Two-Part Study Comparing Gedatolisib in Combination with Palbociclib and Fulvestrant to Standard-Of-Care Therapies in Patients with HR-Positive, HER2-Negative Advanced Breast Cancer Previously Treated with a CDK4/6 Inhibitor in Combination with Non-Steroidal Aromatase Inhibitor Therapy (VIKTORIA-1)

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Jeanine L Werner, M.D.

Disease Types

Sponsor

  • Celcuity Inc. PSI-CRO

ClinicalTrials.gov NCT ID

  • NCT05501886